|
Match
|
Document |
Document Title |
|
|
US20120041274 |
CANCER BIOMARKERS
Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.
|
|
|
US20120053253 |
GENE SIGNATURES FOR CANCER PROGNOSIS
Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.
|
|
|
US20110313058 |
METHOD AND APPARATUS FOR LIMITING GROWTH OF EYE LENGTH
Certain embodiments of the present invention are directed to therapeutic intervention in patients with eye-length-related disorders to prevent, ameliorate, or reverse the effects of the...
|
|
|
US20090142453 |
Nutraceutical Coatings fo Fruits and Vegetables
A preharvest coating for fruits, vegetables and other plants includes a primary ingredient for protecting the fruit, vegetable or plant from physical harm or damage during growing and harvesting...
|
|
|
US20070298080 |
Strain of Lactobacillus Acidophilus Having Analgesic Properties in the Gastrointestinal System
The invention proposes the use of at least one strain of Lactobacillus acidophilus to prepare a support administered to humans or animals with an analgesic purpose in the gastrointestinal system.
|
|
|
US20120095117 |
GALECTIN-3 nsSNP MARKER FOR CANCER
A diagnostic biomarker including a mechanism for determining a patient's propensity to develop cancer. A diagnostic kit for determining a patient's propensity to develop cancer. A method of...
|
|
|
US20120041082 |
METHODS OF USING SMAD3 AND JAK2 GENETIC VARIANTS TO DIAGNOSE AND PREDICT INFLAMMATORY BOWEL DISEASE
Disclosed are methods of diagnosing Inflammatory Bowel Disease by determining the presence or absence of genetic variants at SMAD3 and/or JAK2 loci. Provided is a method of diagnosing a Crohn's...
|
|
|
US20110086926 |
Disabling thymus gland as a new method for treatment of multiple sclerosis
This invention is related to the treatment of the Multiple Sclerosis (MS). In this invention the disabling thymus gland is suggested as a new method of treatment for MS. This proposed method can be...
|
|
|
US20100324154 |
ASSESSING SUSCEPTIBILITY TO VASCULAR DISORDERS
The invention provides methods and reagents for determination of risk and treatment of a vascular disorder such as abdominal aortic aneurysm (AAA) by detecting presence of gene polymorphisms and/or...
|
|
|
US20120064009 |
METHODS OF LEUKEMIA CELL DETECTION
Methods are provided for, inter alia, determining the presence of leukemia cells in a subject, determining the change or potential change in the number of leukemia cells in the subject with time,...
|
|
|
US20120129957 |
ANALYZING THE FMR1 GENE
A method of screening a human for risk of malignancies is disclosed. The method may include isolating the human's FMR1 gene, wherein the FMR1 gene has a first allele and a second allele, measuring...
|
|
|
US20110218253 |
IMAGING-BASED IDENTIFICATION OF A NEUROLOGICAL DISEASE OR A NEUROLOGICAL DISORDER
System(s) and method(s) are provided to enable imaging-based identification, detection, evaluation, and mapping of white matter microstructure and hemispheric organization of white matter in a...
|
|
|
US20110124744 |
Magnetic Resonance-Based Viscometers and Methods
This invention relates generally to magnetic resonance (MR)-based methods and kits for measuring the viscosity of liquid samples.
|
|
|
US20120035279 |
PROTOCOL FOR SCREENING TRAVELERS
Methods for screening a traveler for an evaluation of the traveler's physical condition or health status by obtaining at least one specimen from the traveler and subjecting the specimen to at least...
|
|
|
US20110224313 |
COMPOSITIONS AND METHODS FOR CLASSIFYING LUNG CANCER AND PROGNOSING LUNG CANCER SURVIVAL
The application provides methods of prognosing, diagnosing, screening and classifying lung cancer patients into poor survival groups or good survival groups. A number of altered genomic regions...
|
|
|
US20110257628 |
INSTRUMENT FOR ALLEVIATING ADDICTIVE DRUG CRAVING, METHOD FOR USING SAME AND METHOD FOR TREATING ADDICTIVE DRUG DEPENDENCE
Provided is an instrument for alleviating addictive drug craving which can be safely administered to an addictive drug-dependent patient by a definite method in practice without causing any...
|
|
|
US20110171320 |
Methods to extend vision to infrared wavelengths
In a method for visualizing an object under conditions of low ambient light, the object to be visualized is exposed to incident electromagnetic radiation having a wavelength greater than what can...
|
|
|
US20110269852 |
METHODS AND MECHANISMS INVOLVING HYPERPIGMENTATION PARTICULARLY FOR AFRICAN AMERICAN SKIN
Sets of genes are identified that show modulated activity in hyperpigmented sun-exposed (HE) and non-hyperpigmented sun-exposed (NHE) skin, when compared to non-hyperpigmented non-exposed (NHNE)...
|
|
|
US20110237688 |
METHODS AND COMPOSITIONS RELATED TO ACETYLOCHOLINE RECEPTOR CONJUGATES
Disclosed are methods, compositions, and diagnostic kits for detecting acetylcholine receptor (AchR) autoreactive immune cells in a subject. The methods comprise detecting the binding of...
|
|
|
US20060014839 |
Combination of angiotensin II receptor blocker and beta-blocker for secondary prevention of myocardial infarction
The invention relates to a method of treating cardiovascular disease in patients following myocardial infarction comprising administering an effective amount of an ARB, especially valsartan, in...
|
|
|
US20070299010 |
CPG15 and CPG15-2 compounds and inhibitors as insulin receptor and insulin-like growth factor receptor agonists and antagonists
Disclosed herein are CPG15 and CPG15-2 compounds and inhibitors that act as agonists and antagonists of the insulin receptor and insulin-like growth factor receptors, and the use of such...
|
|
|
US20090155324 |
Skin Treatment System
A skin treatment system includes a flexible panel having an outer surface and an inner surface. The flexible panel may be configured to surround at least a portion of a user's appendage. The skin...
|
|
|
US20110195051 |
USE OF BACTERIA OF THE GENUS TENACIBACULUM FOR QUORUM QUENCHING
Use of bacterial cells of the genus Tenacibaculum, from the crude cellular extract or from its cultivation supernatants, capable of degrading N-acyl homoserine lactones, for quorum quenching, for...
|
|
|
US20080058429 |
Diagnosis Of Primary Open Angle Glaucoma
The invention provides methods for diagnosing patients with primary open angle glaucoma (POAG), as well as methods for identifying agents for use in treating POAG and methods of using such agents...
|
|
|
US20090092693 |
Platelet manipulation to prevent and treat endovascular disease and its sequelae, to prevent and treat arrhythmias and to prevent malignancy
Reduction of platelet counts to below 150 thousand per cubic millimeter by pharmacologic, mechanical, combined mechanical and pharmacological, or other means for the purpose of reducing the...
|
|
|
US20110230571 |
DIAGNOSTIC AND THERAPEUTIC PROTOCOLS
The present invention relates to methods for determining co-receptor usage of an HIV in a subject including the steps of: culturing a viral preparation derived from the subject's plasma with one or...
|
|
|
US20110086925 |
Method and System to Detect, Diagnose, and Monitor the Progression of Alzheimer's Disease
Various embodiments provide methods for the detection, the diagnosis, and/or the progression monitoring of Alzheimer's disease by observing the epigenetic markers in leukocytes. Methods for...
|
|
|
US20110152385 |
NUCLEIC ACIDS AND METHODS FOR DETECTING TURFGRASS PATHOGENIC FUNGI
The present invention relates to the use of at least one nucleic acid comprising or consisting of: (i) CATCGAT-GAAGAACGCWGCRAAHTGCGATAMGTARTGYGAATTGCAGRATTCAGTGART
CATCGAAWYTTTGAACG-CAYMTTGCRC (SEQ...
|
|
|
US20080139614 |
Treatment Of Stroke With Histamine H3 Inverse Agonists Or Histamine H3 Antagonists
Histamine H3 inverse agonists or histamine H3 antagonists are useful, alone or in combination with an anti-stroke agent, for treating stroke.
|
|
|
US20080020037 |
Acoustic Pharma-Informatics System
Compositions, systems and methods that allow for the detection of the actual physical delivery of a pharmaceutical agent to a body are provided. Embodiments of the compositions include an acoustic...
|
|
|
US20080254074 |
COMPOSITION AND METHOD FOR REGULATING SEBUM FLOW
A skin care composition for regulating sebum flow from sebocytes is described. The composition comprises spheroids, and optionally, thickening agents and when a spheroid and sebum mixture is made...
|
|
|
US20080200566 |
Dephosphorylation of HDAC7 By Myosin Phosphatase
The present invention relates to screening methods that make use of a histone deacetylase interacting with a myosin phosphatase for the identification of novel therapeutics useful for inhibiting or...
|
|
|
US20070265294 |
Formulations and methods for vascular permeability-related diseases or conditions
Described herein are formulations and methods for treating, inhibiting, preventing, delaying onset, or causing regression of a disease or condition relating to vascular permeability.
|
|
|
US20070269443 |
Therapeutic Regimens for Baff Antagonists
Therapeutic regimens for administration of BAFF antagonists for treatment of immunologic and related disorders are described. Regimens involve a short-term BAFF antagonist administration course...
|
|
|
US20080035141 |
AEROSOLIZED THERAPY KIT
A comprehensive aerosol therapy for administration to a patient in need of treatment is provided. More particularly, the aerosol therapy kit provides a seamless conduit for a patient to receive...
|
|
|
US20100210738 |
PROGNOSTIC BIOMARKERS TO PREDICT OVERALL SURVIVAL AND METASTATIC DISEASE IN PATIENTS WITH TRIPLE NEGATIVE BREAST CANCER
The present invention relates to a method for prognosing cancer in a subject with triple negative (TN) breast cancer, whose tumors lack expression of the estrogen receptor (ER), the progesterone...
|
|
|
US20050126579 |
Theory of bell's palsy
The Theory of Bell's Palsy derived from scientific evidences states that there are two types of facial paralysis based on two distinct inciting etiologies wherein a first facial paralysis is caused...
|
|
|
US20100280134 |
Markers for Bladder Cancer Detection
A method of detecting a predisposition to, or the incidence of, bladder cancer in a sample comprises detecting an epigenetic change in at least one gene selected from TWIST1, NID2, RUNX3, BMP7,...
|
|
|
US20080069864 |
Delivery System for Cosmetic and Skincare Products
Cosmetic and skin care products are dispersed or encapsulated within a polymer matrix to provide a convenient means of storing and transporting the cosmetic or skin care product prior to use. Prior...
|
|
|
US20080132586 |
Use of Methionine Synthase Inhibitors for the Treatment of Fungal Diseases of Crops
The invention relates to the use of methionine synthase inhibitors for the treatment of fungal diseases of crops. The invention further relates to methods for treatment of crops against fungal...
|
|
|
US20080027052 |
METHODS FOR TREATING CYSTIC KIDNEY DISEASE
The present invention relates to methods for treating or preventing cystic kidney diseases or disorders using calcimimetics and pharmaceutically acceptable salts of these compounds. Various aspects...
|
|
|
US20080058431 |
Modulators of Shp2 Tyrosine Phosphatase and Their Use in the Treatment of Body Weight Disorders
Described are methods and compositions for regulating body weight and/or regulating the rate of weight gain or loss, and particularly, for treating or preventing obesity. Specifically, methods of...
|
|
|
US20100144903 |
METHODS OF DIAGNOSIS AND TREATMENT OF CROHN'S DISEASE
In one embodiment, this invention provides methods of diagnosing and/or predicting susceptibility to Crohn's Disease by determining the presence or absence of risk haplotypes in IL23R, IL17A,...
|
|
|
US20090048659 |
Medical devices having sol-gel derived ceramic regions with molded submicron surface features
According to one aspect of the present invention, implantable or insertable medical devices are provided, which contain sol-gel derived ceramic regions which have molded submicron surface features.
|
|
|
US20080032961 |
Therapy employing LXRalpha modolators
The invention also relates to the use of active modulators of LXRα activity or expression in stimulation of pre-adipocyte differentiation and hence also in the treatment of insulin resistance ...
|
|
|
US20110136922 |
ACTIVATION INDUCED DEAMINASE (AID)
The invention is directed to a cell comprising a nucleic acid encoding an Activation Induced Deaminase (AID) polypeptide, a fusion protein comprising an AID polypeptide, and methods of using a...
|
|
|
US20070265194 |
Agents for the treatment of viral infections
The invention relates to methods of treating a hepatitus virus infection by administering a therapeutically effective amount of a proteasome inhibitor and a pharmaceutically acceptable carrier to a...
|
|
|
US20080317835 |
Personalized Nutrient Deficiency Assay Methods
Assays are preformed to determine nutrient deficiency levels in an individual to address the deficiencies and improve health and longevity. Nutraceutical and cosmeceutical products containing...
|
|
|
US20080262109 |
METHOD FOR PRODUCING LIQUID PREPARATIONS HAVING A SOLID BODY CONTENT
A method for producing a liquid preparation having a solid body content and the resulting liquid preparation. According to the method, the addition of at least a portion of the solid bodies takes...
|
|
|
US20080147022 |
Skin care delivery device having a releasable backing
A skin care delivery device is disclosed. The skin care delivery device includes a substrate containing a skin care composition. The skin care composition can comprise, for instance, any suitable...
|